The current issue of CEJU brings a somewhat ambiguous paper entitled “Vitamin D and urological cancers” describing (possible) role of the vit. D in the etiology of urological cancers [1]. Indeed, last years brought numerous publications presenting that 1,25-dihydroxyvitamin D3 may alter human susceptibility to different diseases (even improve fitness) and its capability to cure or, at least, to soothe some human cancers [2, 3, 4]. Such contribution of the vit. D has been debated widely elsewhere, became trendy in contemporary medicine and engaged a great number of researches. Vit D and polymorphism of its targeted receptors have been harnessed to the etiology of: hypertension, bronchial asthma, type 2 diabetes mellitus, autoimmune disorders, cognitive decline and so forth [5]. Some studies suggest that vit. D receptor polymorphism may play a role in the prostate cancer, bladder cancer and other malicious tumours [6, 7]. Its role in the progress of the colon cancer has been scientifically proven [6]. The evidence for a protective effect of vitamin D on the risk of breast cancer has been published before. Thus, it looked that medicine found a gorgeous but simple and attainable remedy for almost everything.
Paper under discussion keeps pace with that papers and I am convinced that is worthy of notice as a well-tailored analysis adding a new twist to that issue [1].
Although considerable progress has been made toward understanding tumours etiology and the role of vit. D in human pathology, its role in cancer is still unclear [8, 9], Some papers present conflicting data clearly demonstrated in the manuscript under debate. Authors performed a survey of eligible studies on above mentioned possible association [1]. Its real scientific merit consist in concentration of a large group of data – it is an undisputed value of that paper.
Apparently, pinning high hopes on the vit D is a risky business. A consultative committee – US Preventive Services Task Force concluded that all these data are insufficient [10]. Probably other factors that contribute to overall good health status, like healthy lifestyle with befitting physical activity, keeping healthy and balanced diet may intermingle with vit D level. In the light of that it is possible that some trials confused causes and effects. Well, a distinction should be made between the primary and secondary outcome but we do not confidently know which came first: the chicken or the egg? Moreover, next trials questioned the validity of before published research.
A large volume meta-analysis (290 prospective observational studies and 172 random trials) indeed confirmed inversely proportional interrelation of the level of vit. D and incidence of cardiovascular, metabolic, inflammatory, neurologic and psychiatric disorders (even Alzheimer disease) but could not indicate the primary cause and secondary effect. Also, another authors found that vit. D supplementation had at most insignificant therapeutic effect on the above conditions [11].
It is apparent that the existing evidence to guide us on the subject of the vit. D supplementation is vague and volatile and is based on conflicting data. Nevertheless, there is one certain axiom that have emerged from above citations: complying with balanced, sagacious and healthy life style undoubtedly helps to keep vit. D and the risk of numerous diseases on a safe level.
References
- 1.Krajewski W, Dzięgała M, Kołodziej A, Dembowski J, Zdrojowy R. Vitamin D and urological cancers. Cent European J Urol. 2016;69:139–147. doi: 10.5173/ceju.2016.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Garland FC, Garland CF, Gorham ED, Young JF. Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med. 1990;19:614–622. doi: 10.1016/0091-7435(90)90058-r. [DOI] [PubMed] [Google Scholar]
- 3.Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999;889:107–119. doi: 10.1111/j.1749-6632.1999.tb08728.x. [DOI] [PubMed] [Google Scholar]
- 4.Toffanello ED, Perissinotto E, Sergi G, et al. Vitamin D and physical performance in elderly subjects: the Pro.V.A study. PLoS One. 2012;7:e34950. doi: 10.1371/journal.pone.0034950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85:1586–1591. doi: 10.1093/ajcn/85.6.1586. [DOI] [PubMed] [Google Scholar]
- 6.McDonnell SL, Baggerly C, French CB, et al. Serum 25-Hydroxyvitamin D Concentrations ≥ 40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study. PLoS One. 2016;11(4):e0152441. doi: 10.1371/journal.pone.0152441. eCollection 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Shui IM, Mucci LA, Kraft P, et al. Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012;104:690–699. doi: 10.1093/jnci/djs189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Arem H, Yu K, Xiong X, et al. Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. PLoS ONE. 2015;10:e0117574. doi: 10.1371/journal.pone.0117574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Carlberg C, Seuter S, de Mello VD, et al. Primary vitamin D target genes allow a categorization of possible benefits of vitamin D3 supplementation. PLoS One. 2013;8:e71042. doi: 10.1371/journal.pone.0071042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Manson JE, Bassuk SS. Vitamin D research and clinical practice: at a crossroads. JAMA. 2015;313:1311–1312. doi: 10.1001/jama.2015.1353. [DOI] [PubMed] [Google Scholar]
- 11.Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2:76–89. doi: 10.1016/S2213-8587(13)70165-7. [DOI] [PubMed] [Google Scholar]